0->Consider the task of determining semantic entailment relations between individual sections of Clinical Trial Reports (CTRs) and statements made by clinical domain experts. Note that CTRs outline the methodology and findings of a clinical trial, which are conducted to assess the effectiveness and safety of new treatments. Each trial involves 1-2 patient groups, called cohorts or arms, and these groups may receive different treatments, or have different baseline characteristics. The complete CTRs contain 4 sections, corresponding to (1) a list of the ELIGIBILITY CRITERIA corresponding to the conditions for patients to be allowed to take part in the clinical trial, (2) a description for the INTERVENTION that specifies the type, dosage, frequency, and duration of treatments being studied, (3) a summary of the RESULTS, detailing aspects such as the number of participants in the trial, the outcome measures, the units, and the conclusions, and (4) a list of ADVERSE EVENTS corresponding to signs and symptoms observed in patients during the clinical trial. In turn, the statements are sentences that make some type of claim about the information contained in one of the aforementioned sections, either considering a single CTR or comparing two CTRs. In order for the entailment relationship to be established, the claim in the statement should be related to the clinical trial information, it should be supported by the CTR, and it must not contradict the provided descriptions.
----------
1->

Perform a comprehensive semantic analysis of Clinical Trial Reports (CTRs) focusing on clinical protocols, evaluating the efficacy and safety profiles of innovative treatments. Segment the analysis into four key areas: 

1. Specify Participant Eligibility Criteria, detailing the inclusion criteria.

2. Describe Treatment Details, including the intervention type, dosage, administration frequency, and treatment duration.

3. Elaborate on Clinical Outcomes Measurement, outlining participant count, outcome measures, units of measurement, and trial results.

4. Document Adverse Effects, listing observed symptoms in patients.

Ensure all information is medically accurate, data-backed from CTRs, and consistent within each segment's content.
----------
2->

Perform a comprehensive semantic analysis of Clinical Trial Reports (CTRs) to evaluate clinical protocols, focusing on the efficacy and safety of therapeutic agents. The analysis should be divided into four key areas: 

1. Define Participant Eligibility Criteria, detailing inclusion criteria.

2. Describe Treatment Details, specifying intervention type, dosage, administration frequency, and treatment duration.

3. Elucidate Clinical Outcomes Measurement, including participant count, outcome measures, units of measurement, and trial results.

4. Document Adverse Effects, detailing observed symptoms in patients.

Ensure all information is medically accurate, data-supported, and internally consistent within each segment. Additionally, determine semantic entailment relations between sections of CTRs and expert statements, ensuring claims are related to trial information, supported by CTRs, and non-contradictory.
----------
3->

Conduct an in-depth semantic dissection of Clinical Trial Reports (CTRs), with an emphasis on scrutinizing clinical protocols to assess the therapeutic interventions' effectiveness and safety. Segment the analysis into four critical components: (1) Define the Participant Eligibility Criteria, specifying the inclusion criteria, (2) Describe the Treatment Details, including types of interventions, dosages, administration schedules, and treatment lengths, (3) Explain the Clinical Outcomes Measurement, detailing participant numbers, outcome metrics, units of measurement, and conclusions drawn from the trial, and (4) Document Adverse Effects, noting any symptoms experienced by patients. Maintain medical precision, substantiate claims with data, and ensure consistency within each segment.
----------
4->

Perform a comprehensive semantic analysis of Clinical Trial Reports (CTRs) in relation to clinical protocols, focusing on evaluating the effectiveness and safety of innovative treatments. The analysis should be divided into four key areas:

1. Eligibility Criteria for Participants: Clearly define the inclusion criteria necessary for participation.

2. Treatment Specifications: Provide a detailed description of the intervention, including type, dosage, administration frequency, and treatment duration.

3. Clinical Findings: Report the number of participants, outcome measures, units of measurement, and results obtained from the trial.

4. Documented Adverse Reactions: Record any observed adverse symptoms experienced by the participants.

Ensure all information is medically accurate, backed by data from CTRs, and maintains internal consistency within each section's content.
----------
